{"pmid":32470316,"title":"Investigation and Serologic Follow-Up of Contacts of Early Confirmed Case-Patient with COVID-19, United States.","text":["Investigation and Serologic Follow-Up of Contacts of Early Confirmed Case-Patient with COVID-19, United States.","We describe the contact investigation for an early confirmed case of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in the United States. Contacts of the case-patient were identified, actively monitored for symptoms, interviewed for a detailed exposure history, and tested for SARS-CoV-2 infection by real-time reverse transcription PCR (rRT-PCR) and ELISA. Fifty contacts were identified and 38 (76%) were interviewed, of whom 11 (29%) reported unprotected face-to-face interaction with the case-patient. Thirty-seven (74%) had respiratory specimens tested by rRT-PCR, and all tested negative. Twenty-three (46%) had ELISA performed on serum samples collected approximately 6 weeks after exposure, and none had detectable antibodies to SARS-CoV-2. Among contacts who were tested, no secondary transmission was identified in this investigation, despite unprotected close interactions with the infectious case-patient.","Emerg Infect Dis","Chu, Victoria T","Freeman-Ponder, Brandi","Lindquist, Scott","Spitters, Christopher","Kawakami, Vance","Dyal, Jonathan W","Clark, Shauna","Bruce, Hollianne","Duchin, Jeffrey S","DeBolt, Chas","Podczervinski, Sara","D'Angeli, Marisa","Pettrone, Kristen","Zacks, Rachael","Vahey, Grace","Holshue, Michelle L","Lang, Misty","Burke, Rachel M","Rolfes, Melissa A","Marlow, Mariel","Midgley, Claire M","Lu, Xiaoyan","Lindstrom, Stephen","Hall, Aron J","Fry, Alicia M","Thornburg, Natalie J","Gerber, Susan I","Pillai, Satish K","Biggs, Holly M","32470316"],"abstract":["We describe the contact investigation for an early confirmed case of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in the United States. Contacts of the case-patient were identified, actively monitored for symptoms, interviewed for a detailed exposure history, and tested for SARS-CoV-2 infection by real-time reverse transcription PCR (rRT-PCR) and ELISA. Fifty contacts were identified and 38 (76%) were interviewed, of whom 11 (29%) reported unprotected face-to-face interaction with the case-patient. Thirty-seven (74%) had respiratory specimens tested by rRT-PCR, and all tested negative. Twenty-three (46%) had ELISA performed on serum samples collected approximately 6 weeks after exposure, and none had detectable antibodies to SARS-CoV-2. Among contacts who were tested, no secondary transmission was identified in this investigation, despite unprotected close interactions with the infectious case-patient."],"journal":"Emerg Infect Dis","authors":["Chu, Victoria T","Freeman-Ponder, Brandi","Lindquist, Scott","Spitters, Christopher","Kawakami, Vance","Dyal, Jonathan W","Clark, Shauna","Bruce, Hollianne","Duchin, Jeffrey S","DeBolt, Chas","Podczervinski, Sara","D'Angeli, Marisa","Pettrone, Kristen","Zacks, Rachael","Vahey, Grace","Holshue, Michelle L","Lang, Misty","Burke, Rachel M","Rolfes, Melissa A","Marlow, Mariel","Midgley, Claire M","Lu, Xiaoyan","Lindstrom, Stephen","Hall, Aron J","Fry, Alicia M","Thornburg, Natalie J","Gerber, Susan I","Pillai, Satish K","Biggs, Holly M"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470316","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3201/eid2608.201423","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","contact tracing","coronavirus","coronavirus disease","respiratory infections","serology","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["United States","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention","Diagnosis"],"weight":1,"_version_":1668420887284547585,"score":9.490897,"similar":[{"pmid":32267220,"title":"Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients.","text":["Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients.","A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged to cause a human pandemic. Although molecular diagnostic tests were rapidly developed, serologic assays are still lacking, yet urgently needed. Validated serologic assays are needed for contact tracing, identifying the viral reservoir, and epidemiologic studies. We developed serologic assays for detection of SARS-CoV-2 neutralizing, spike protein-specific, and nucleocapsid-specific antibodies. Using serum samples from patients with PCR-confirmed SARS-CoV-2 infections, other coronaviruses, or other respiratory pathogenic infections, we validated and tested various antigens in different in-house and commercial ELISAs. We demonstrated that most PCR-confirmed SARS-CoV-2-infected persons seroconverted by 2 weeks after disease onset. We found that commercial S1 IgG or IgA ELISAs were of lower specificity, and sensitivity varied between the 2 assays; the IgA ELISA showed higher sensitivity. Overall, the validated assays described can be instrumental for detection of SARS-CoV-2-specific antibodies for diagnostic, seroepidemiologic, and vaccine evaluation studies.","Emerg Infect Dis","Okba, Nisreen M A","Muller, Marcel A","Li, Wentao","Wang, Chunyan","GeurtsvanKessel, Corine H","Corman, Victor M","Lamers, Mart M","Sikkema, Reina S","de Bruin, Erwin","Chandler, Felicity D","Yazdanpanah, Yazdan","Le Hingrat, Quentin","Descamps, Diane","Houhou-Fidouh, Nadhira","Reusken, Chantal B E M","Bosch, Berend-Jan","Drosten, Christian","Koopmans, Marion P G","Haagmans, Bart L","32267220"],"abstract":["A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged to cause a human pandemic. Although molecular diagnostic tests were rapidly developed, serologic assays are still lacking, yet urgently needed. Validated serologic assays are needed for contact tracing, identifying the viral reservoir, and epidemiologic studies. We developed serologic assays for detection of SARS-CoV-2 neutralizing, spike protein-specific, and nucleocapsid-specific antibodies. Using serum samples from patients with PCR-confirmed SARS-CoV-2 infections, other coronaviruses, or other respiratory pathogenic infections, we validated and tested various antigens in different in-house and commercial ELISAs. We demonstrated that most PCR-confirmed SARS-CoV-2-infected persons seroconverted by 2 weeks after disease onset. We found that commercial S1 IgG or IgA ELISAs were of lower specificity, and sensitivity varied between the 2 assays; the IgA ELISA showed higher sensitivity. Overall, the validated assays described can be instrumental for detection of SARS-CoV-2-specific antibodies for diagnostic, seroepidemiologic, and vaccine evaluation studies."],"journal":"Emerg Infect Dis","authors":["Okba, Nisreen M A","Muller, Marcel A","Li, Wentao","Wang, Chunyan","GeurtsvanKessel, Corine H","Corman, Victor M","Lamers, Mart M","Sikkema, Reina S","de Bruin, Erwin","Chandler, Felicity D","Yazdanpanah, Yazdan","Le Hingrat, Quentin","Descamps, Diane","Houhou-Fidouh, Nadhira","Reusken, Chantal B E M","Bosch, Berend-Jan","Drosten, Christian","Koopmans, Marion P G","Haagmans, Bart L"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267220","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.3201/eid2607.200841","keywords":["covid-19","elisa","hcov","rbd","sars-cov-2","severe acute respiratory syndrome coronavirus 2","antibodies","coronavirus","coronavirus disease 2019","human coronavirus","neutralization","nucleocapsid protein","receptor-binding domain","respiratory infections","serologic analysis","spike protein","viruses","zoonoses"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491931590658,"score":355.9971},{"pmid":32396505,"title":"US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.","text":["US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the etiologic agent associated with coronavirus disease, which emerged in late 2019. In response, we developed a diagnostic panel consisting of 3 real-time reverse transcription PCR assays targeting the nucleocapsid gene and evaluated use of these assays for detecting SARS-CoV-2 infection. All assays demonstrated a linear dynamic range of 8 orders of magnitude and an analytical limit of detection of 5 copies/reaction of quantified RNA transcripts and 1 x 10(-1.5) 50% tissue culture infectious dose/mL of cell-cultured SARS-CoV-2. All assays performed comparably with nasopharyngeal and oropharyngeal secretions, serum, and fecal specimens spiked with cultured virus. We obtained no false-positive amplifications with other human coronaviruses or common respiratory pathogens. Results from all 3 assays were highly correlated during clinical specimen testing. On February 4, 2020, the Food and Drug Administration issued an Emergency Use Authorization to enable emergency use of this panel.","Emerg Infect Dis","Lu, Xiaoyan","Wang, Lijuan","Sakthivel, Senthilkumar K","Whitaker, Brett","Murray, Janna","Kamili, Shifaq","Lynch, Brian","Malapati, Lakshmi","Burke, Stephen A","Harcourt, Jennifer","Tamin, Azaibi","Thornburg, Natalie J","Villanueva, Julie M","Lindstrom, Stephen","32396505"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the etiologic agent associated with coronavirus disease, which emerged in late 2019. In response, we developed a diagnostic panel consisting of 3 real-time reverse transcription PCR assays targeting the nucleocapsid gene and evaluated use of these assays for detecting SARS-CoV-2 infection. All assays demonstrated a linear dynamic range of 8 orders of magnitude and an analytical limit of detection of 5 copies/reaction of quantified RNA transcripts and 1 x 10(-1.5) 50% tissue culture infectious dose/mL of cell-cultured SARS-CoV-2. All assays performed comparably with nasopharyngeal and oropharyngeal secretions, serum, and fecal specimens spiked with cultured virus. We obtained no false-positive amplifications with other human coronaviruses or common respiratory pathogens. Results from all 3 assays were highly correlated during clinical specimen testing. On February 4, 2020, the Food and Drug Administration issued an Emergency Use Authorization to enable emergency use of this panel."],"journal":"Emerg Infect Dis","authors":["Lu, Xiaoyan","Wang, Lijuan","Sakthivel, Senthilkumar K","Whitaker, Brett","Murray, Janna","Kamili, Shifaq","Lynch, Brian","Malapati, Lakshmi","Burke, Stephen A","Harcourt, Jennifer","Tamin, Azaibi","Thornburg, Natalie J","Villanueva, Julie M","Lindstrom, Stephen"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32396505","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3201/eid2608.201246","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","coronavirus disease","real-time rt-pcr","real-time reverse transcription pcr","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis"],"weight":1,"_version_":1666627827924992000,"score":318.00412},{"pmid":32294051,"title":"Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2.","text":["Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2.","Most reverse transcription PCR protocols for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) include 2-3 targets for detection. We developed a triplex, real-time reverse transcription PCR for SARS-CoV-2 that maintained clinical performance compared with singleplex assays. This protocol could streamline detection and decrease reagent use during current high SARS-CoV-2 testing demands.","Emerg Infect Dis","Waggoner, Jesse J","Stittleburg, Victoria","Pond, Renee","Saklawi, Youssef","Sahoo, Malaya K","Babiker, Ahmed","Hussaini, Laila","Kraft, Colleen S","Pinsky, Benjamin A","Anderson, Evan J","Rouphael, Nadine","32294051"],"abstract":["Most reverse transcription PCR protocols for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) include 2-3 targets for detection. We developed a triplex, real-time reverse transcription PCR for SARS-CoV-2 that maintained clinical performance compared with singleplex assays. This protocol could streamline detection and decrease reagent use during current high SARS-CoV-2 testing demands."],"journal":"Emerg Infect Dis","authors":["Waggoner, Jesse J","Stittleburg, Victoria","Pond, Renee","Saklawi, Youssef","Sahoo, Malaya K","Babiker, Ahmed","Hussaini, Laila","Kraft, Colleen S","Pinsky, Benjamin A","Anderson, Evan J","Rouphael, Nadine"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294051","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.3201/eid2607.201285","keywords":["2019 novel coronavirus disease","covid-19","sars","sars-cov-2","coronavirus","coronavirus disease","molecular detection","rrt-pcr","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494416715777,"score":312.1794},{"pmid":32327757,"title":"Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States.","text":["Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States.","Data on the detailed clinical progression of COVID-19 in conjunction with epidemiological and virological characteristics are limited. In this case series, we describe the first 12 US patients confirmed to have COVID-19 from 20 January to 5 February 2020, including 4 patients described previously(1-3). Respiratory, stool, serum and urine specimens were submitted for SARS-CoV-2 real-time reverse-transcription polymerase chain reaction (rRT-PCR) testing, viral culture and whole genome sequencing. Median age was 53 years (range: 21-68); 8 patients were male. Common symptoms at illness onset were cough (n = 8) and fever (n = 7). Patients had mild to moderately severe illness; seven were hospitalized and demonstrated clinical or laboratory signs of worsening during the second week of illness. No patients required mechanical ventilation and all recovered. All had SARS-CoV-2 RNA detected in respiratory specimens, typically for 2-3 weeks after illness onset. Lowest real-time PCR with reverse transcription cycle threshold values in the upper respiratory tract were often detected in the first week and SARS-CoV-2 was cultured from early respiratory specimens. These data provide insight into the natural history of SARS-CoV-2. Although infectiousness is unclear, highest viral RNA levels were identified in the first week of illness. Clinicians should anticipate that some patients may worsen in the second week of illness.","Nat Med","32327757"],"abstract":["Data on the detailed clinical progression of COVID-19 in conjunction with epidemiological and virological characteristics are limited. In this case series, we describe the first 12 US patients confirmed to have COVID-19 from 20 January to 5 February 2020, including 4 patients described previously(1-3). Respiratory, stool, serum and urine specimens were submitted for SARS-CoV-2 real-time reverse-transcription polymerase chain reaction (rRT-PCR) testing, viral culture and whole genome sequencing. Median age was 53 years (range: 21-68); 8 patients were male. Common symptoms at illness onset were cough (n = 8) and fever (n = 7). Patients had mild to moderately severe illness; seven were hospitalized and demonstrated clinical or laboratory signs of worsening during the second week of illness. No patients required mechanical ventilation and all recovered. All had SARS-CoV-2 RNA detected in respiratory specimens, typically for 2-3 weeks after illness onset. Lowest real-time PCR with reverse transcription cycle threshold values in the upper respiratory tract were often detected in the first week and SARS-CoV-2 was cultured from early respiratory specimens. These data provide insight into the natural history of SARS-CoV-2. Although infectiousness is unclear, highest viral RNA levels were identified in the first week of illness. Clinicians should anticipate that some patients may worsen in the second week of illness."],"journal":"Nat Med","date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327757","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1038/s41591-020-0877-5","locations":["US","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138494577147904,"score":292.2044},{"pmid":32324530,"title":"Coronavirus Disease Outbreak in Call Center, South Korea.","text":["Coronavirus Disease Outbreak in Call Center, South Korea.","We describe the epidemiology of a coronavirus disease (COVID-19) outbreak in a call center in South Korea. We obtained information on demographic characteristics by using standardized epidemiologic investigation forms. We performed descriptive analyses and reported the results as frequencies and proportions for categoric variables. Of 1,143 persons who were tested for COVID-19, a total of 97 (8.5%, 95% CI 7.0%-10.3%) had confirmed cases. Of these, 94 were working in an 11th-floor call center with 216 employees, translating to an attack rate of 43.5% (95% CI 36.9%-50.4%). The household secondary attack rate among symptomatic case-patients was 16.2% (95% CI 11.6%- 22.0%). Of the 97 persons with confirmed COVID-19, only 4 (1.9%) remained asymptomatic within 14 days of quarantine, and none of their household contacts acquired secondary infections. Extensive contact tracing, testing all contacts, and early quarantine blocked further transmission and might be effective for containing rapid outbreaks in crowded work settings.","Emerg Infect Dis","Park, Shin Young","Kim, Young-Man","Yi, Seonju","Lee, Sangeun","Na, Baeg-Ju","Kim, Chang Bo","Kim, Jung-Il","Kim, Hea Sook","Kim, Young Bok","Park, Yoojin","Huh, In Sil","Kim, Hye Kyung","Yoon, Hyung Jun","Jang, Hanaram","Kim, Kyungnam","Chang, Yeonhwa","Kim, Inhye","Lee, Hyeyoung","Gwack, Jin","Kim, Seong Sun","Kim, Miyoung","Kweon, Sanghui","Choe, Young June","Park, Ok","Park, Young Joon","Jeong, Eun Kyeong","32324530"],"abstract":["We describe the epidemiology of a coronavirus disease (COVID-19) outbreak in a call center in South Korea. We obtained information on demographic characteristics by using standardized epidemiologic investigation forms. We performed descriptive analyses and reported the results as frequencies and proportions for categoric variables. Of 1,143 persons who were tested for COVID-19, a total of 97 (8.5%, 95% CI 7.0%-10.3%) had confirmed cases. Of these, 94 were working in an 11th-floor call center with 216 employees, translating to an attack rate of 43.5% (95% CI 36.9%-50.4%). The household secondary attack rate among symptomatic case-patients was 16.2% (95% CI 11.6%- 22.0%). Of the 97 persons with confirmed COVID-19, only 4 (1.9%) remained asymptomatic within 14 days of quarantine, and none of their household contacts acquired secondary infections. Extensive contact tracing, testing all contacts, and early quarantine blocked further transmission and might be effective for containing rapid outbreaks in crowded work settings."],"journal":"Emerg Infect Dis","authors":["Park, Shin Young","Kim, Young-Man","Yi, Seonju","Lee, Sangeun","Na, Baeg-Ju","Kim, Chang Bo","Kim, Jung-Il","Kim, Hea Sook","Kim, Young Bok","Park, Yoojin","Huh, In Sil","Kim, Hye Kyung","Yoon, Hyung Jun","Jang, Hanaram","Kim, Kyungnam","Chang, Yeonhwa","Kim, Inhye","Lee, Hyeyoung","Gwack, Jin","Kim, Seong Sun","Kim, Miyoung","Kweon, Sanghui","Choe, Young June","Park, Ok","Park, Young Joon","Jeong, Eun Kyeong"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324530","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.3201/eid2608.201274","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","south korea","call center","coronavirus disease","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["South Korea","South Korea"],"countries":["Korea, Republic of"],"countries_codes":["KOR|Korea, Republic of"],"topics":["Prevention","Transmission"],"weight":1,"_version_":1666138493811687424,"score":287.45627}]}